Clinical Trial Update: Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Bazedoxifene/Conjugated Estrogens on endometrial safety and postmenopausal osteoporosis has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Osteoporosis

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Conjugated Estrogens (ESTROGENS, CONJUGATED)

Snippet

Sponsor: Pfizer | Conditions: Menopause, Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2013-12-20